TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,632 | -57.8% | 195,167 | +25.4% | 0.02% | -48.4% |
| Q2 2023 | $3,866 | +992.1% | 155,648 | +560.5% | 0.03% | +933.3% |
| Q1 2023 | $354 | -100.0% | 23,565 | -82.7% | 0.00% | -72.7% |
| Q3 2022 | $805,000 | +257.8% | 136,021 | +157.4% | 0.01% | +266.7% |
| Q2 2022 | $225,000 | -51.3% | 52,853 | +8.7% | 0.00% | -50.0% |
| Q1 2022 | $462,000 | +260.9% | 48,630 | +112.6% | 0.01% | +50.0% |
| Q3 2019 | $128,000 | -35.0% | 22,877 | +0.4% | 0.00% | -50.0% |
| Q2 2019 | $197,000 | – | 22,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 1,647,000 | $6,423,000 | 0.45% |
| DAFNA Capital Management LLC | 75,000 | $293,000 | 0.30% |
| Baker Brothers Advisors | 2,199,656 | $8,579,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 71,105 | $277,000 | 0.05% |
| SMITH ASSET MANAGEMENT GROUP LP | 196,684 | $767,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 66,000 | $257,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,000 | $4,000 | 0.01% |
| COLUMBUS CIRCLE INVESTORS | 161,919 | $631,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 455,271 | $1,776,000 | 0.00% |
| BlackRock Fund Advisors | 448,445 | $1,749,000 | 0.00% |